Advertisement

Alkem Laboratories News

alt
Drug maker Alkem Laboratories on Saturday said it will submit 'suitable clarifications' to the European Medicines Agency (EMA) over a decision by the drug regulator to review two drugs for which clinical trial studies were conducted by the Mumbai-based firm
alt
India`s Alkem Laboratories has been accused by Germany`s health regulator of fudging data on clinical trials of an antibiotic and brain disorder drug, becoming the third Indian firm to be scrutinised since 2014 for suspected manipulation of trial data
alt
Shares of Alkem Laboratories on Friday fell by 7 percent as the UK health regulator made eight observations after inspecting its manufacturing plant at Taloja, Maharashtra.
alt
The stock listed at Rs 1,380, a sharp gain of 31.42 percent over the issue price, on BSE.






Loading...
english news
NEWS ON ONE CLICK